Evaluation of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer.
Christos DamaskosIason PsilopatisAnna GarmpiDimitrios DimitroulisKonstantinos NikolettosKleio VrettouPanagiotis SarantisEvangelos KoustasGregory KouraklisEfstathios A AntoniouMichalis V KaramouzisNikolaos NikolettosPanagiotis TsikourasGeorgios MarinosEmmanouil KontomanolisKonstantinos KontzoglouNikolaos GarmpisPublished in: Cancers (2024)
High HDAC-2 levels in triple negative breast cancer seem to positively influence patient survival, disease stage and recurrence.